E-LIB Suche - Ergebnisse für: Mehta, Manali

1

The cell fate regulator NUPR1 is induced by Mycobacterium l..:

R. Andrade, Priscila ; Mehta, Manali ; Lu, Jing...
PLOS Neglected Tropical Diseases. 13 (2019) 7 - p. e0007589 , 2019

Link: https://doi.org/10.1371/..

2

Plasticity of antimicrobial and phagocytic programs in huma..:

Montoya, Dennis ; Mehta, Manali ; Ferguson, Benjamin G....
Immunology. 156 (2018) 2 - p. 164-173 , 2018

Link: https://doi.org/10.1111/..

3

microRNAs in mycobacterial disease: friend or foe?:

Mehta, Manali D. ; Liu, Philip T.
Frontiers in Genetics. 5 (2014) - p. , 2014

Link: https://doi.org/10.3389/..

4

The cell fate regulator NUPR1 is induced by Mycobacterium l..:

Andrade, Priscila R ; Mehta, Manali ; Lu, Jing...
qt3sg7m39n. , 2019

Link: https://escholarship.org..

5

Molecular mechanisms by which Mycobacterium leprae survives..:

Mehta, Manali D
qt46x650wq. , 2016

Link: https://escholarship.org..

6

microRNAs in mycobacterial disease: friend or foe?:

Mehta, Manali D ; Liu, Philip T
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

7

MicroRNA-21 targets the vitamin D–dependent antimicrobial p..:

Liu, Philip T ; Wheelwright, Matthew ; Teles, Rosane...
qt7w46r1m5. , 2012

Link: https://escholarship.org..

8

MicroRNA-21 targets the vitamin D-dependent antimicrobial p..:

Liu, Philip T ; Wheelwright, Matthew ; Teles, Rosane...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274599. , 2012

Link: http://www.ncbi.nlm.nih...

9

The cell fate regulator NUPR1 is induced by Mycobacterium l..:

Priscila R Andrade ; Manali Mehta ; Jing Lu...
https://doi.org/10.1371/journal.pntd.0007589. , 2019

Link: https://doi.org/10.1371/..

10

microRNAs in mycobacterial disease: friend or foe?:

Manali D Mehta ; Philip T Liu
http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00231/full. , 2014

Link: https://doi.org/10.3389/..

11

Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S14 , 2024

Link: https://doi.org/10.1016/..

12

Integrative analysis of clinicopathological features define..:

Vose, Julie M. ; Fu, Kai ; Wang, Lu...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Pri..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S458 , 2023

Link: https://doi.org/10.1016/..

14

Mosunetuzumab with polatuzumab vedotin in relapsed or refra..:

Budde, Lihua E. ; Olszewski, Adam J. ; Assouline, Sarit...
Nature Medicine. 30 (2023) 1 - p. 229-239 , 2023

Link: https://doi.org/10.1038/..

15

POSTER: MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R ..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023

Link: https://doi.org/10.1016/..